Table 4.
Characteristics | Total (n = 419) | No. | % |
---|---|---|---|
Gender | Male | 201 | 48.0% |
Female | 217 | 51.8% | |
Missing | 1 | 0.2% | |
Agea | Mean age (SD), 40 (±19) | ||
0 – 9 | 25 | 6.0% | |
10 – 19 | 49 | 11.7% | |
20 – 29 | 67 | 16.0% | |
30 – 39 | 69 | 16.5% | |
40 – 49 | 61 | 14.6% | |
50 –59 | 84 | 20.0% | |
60 – 69 | 41 | 9.8% | |
70 – 79 | 17 | 4.1% | |
80+ | 6 | 1.4% | |
Status | Alive | 399 | 95.2% |
Deceased | 14 | 3.3% | |
Discharged | 1 | 0.2% | |
Lost to follow-up | 5 | 1.2% | |
Mutated geneb | NFKB1 | 48 | 11.5% |
CTLA4 | 40 | 9.5% | |
TNFRSF13B | 39 | 9.3% | |
NFKB2 | 18 | 4.3% | |
LRBA | 13 | 3.1% | |
STAT3 GOF | 12 | 2.9% | |
ADA2 | 10 | 2.4% | |
STAT1 | 9 | 2.1% | |
STAT3 | 9 | 2.1% | |
IKZF1 | 7 | 1.7% | |
PIK3CD | 7 | 1.7% | |
ICOS | 6 | 1.4% | |
FAS | 5 | 1.2% | |
UNC13D | 3 | 0.7% | |
BACH2 | 2 | 0.5% | |
CARMIL2 | 2 | 0.5% | |
FLG | 2 | 0.5% | |
MST1 | 2 | 0.5% | |
SH2D1A | 2 | 0.5% | |
Other | 22 | 5.3% | |
Not tested | 43 | 10.3% | |
No mutation found | 87 | 20.8% | |
No information availablec | 41 | 9.8% |
aIn case of death, lost to follow-up, and discharge, age at death or last information was used
bSeveral mutated genes per patient are possible. Therefore, percentages do not sum up to 100%
cPending result, or no information